Le Lézard
Classified in: Health, Science and technology
Subjects: NEW PRODUCTS/SERVICES, CALENDAR OF EVENTS, HEALTH, LIFESTYLE, TRADE SHOWS/SEMINARS/WEBINARS

BOAZ to Honour Human Potential with Handcrafted Art Installation at HempFest Edmonton


EDMONTON, Alberta, Feb. 26, 2019 (GLOBE NEWSWIRE) -- BOAZ Pharmaceuticals Inc. (BOAZ) received its license for cultivation in June 2018, and the company is now gearing up for Phase II of expansion as it is in the final stages of obtaining its Sales License. A labour of love is one way to describe the exigent process BOAZ has endured as the independent Licensed Producer (LP) continues to scale.

"It's a unique skill set to be able to put the right structures, systems, processes, and schedules into place while building and motivating a new team to advance a complex regulatory-driven project on a very tight timeline," explains David Isaak, President, and CEO of BOAZ.

BOAZ is known for having earned its LP status in only 10 months without external consultancy, under the Access to Cannabis for Medical Purposes Regulations (ACMPR): the fastest processing time of any facility across Canada. This achievement required great focus and commitment from the entire BOAZ team, and so it comes as no surprise that every detail in the producer's refreshed identity system received the same passionate care and attention that was summoned to earn its LP status.

From a new website to a refreshed logo, BOAZ wanted to honour the sheer perseverance of human potential and pay tribute to the craft process. To highlight its intention, BOAZ also tapped into the creative talents of Calgary-based artist, Carl White, to handcraft a unique piece that fans can truly appreciate and relate to.

"The project has been nurtured and hand built from the ground up. Every leaf was hand carved. I'm proud that we are matching the vision of BOAZ through this," says Carl White, Artist. The cannabis-themed art installation took approximately 100 hours to craft from concept to execution. It pays homage to the meticulous care that BOAZ puts into handcrafting its medical cannabis products.

The handcrafted art installation will be on display at the upcoming HempFest Cannabis Expo in Edmonton, Alberta. In addition to admiring another example of fine Alberta craftsmanship, guests can talk with team members and interact with the display.

The BOAZ team will be stationed at Booth #3 on March 2nd and 3rd, 2019. HempFest Cannabis Expo will be held at the Edmonton Convention Centre. To learn more and purchase tickets, visit https://www.hempfestedmonton.com/.

BOAZ: We're Growing Potential.

About BOAZ

BOAZ Pharmaceuticals Inc. is a privately-owned, Licensed Producer of cannabis. Based in Calgary, Alberta, BOAZ received its official license for cultivation from Health Canada on June 22, 2018. The 20,000 sq. ft. medical marijuana facility began production on July 26, 2018, and has a Sales License in the final stages of application. Media resources available upon request.

Media Contact: David Isaak
President and CEO, Calgary
Email: [email protected]
Phone: 250-262-9410 (Direct Line)

Media Contact: Alison Masniuk
Media Coordinator for BOAZ
Email: [email protected]
Phone: 403-993-9879



These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: